News & Insights
5 Keys to Successfully Raising Series B and Later Rounds for SaaS Companies
Much has already been written regarding raising capital that talks about the need to start a process early, getting your pitch right, and that you should talk to a wide spectrum of investors. Whilst all true, what isn’t as well covered are the specifics of what you need to do to improve your chances of […]
BIO International in San Diego: Sunny with scattered economic clouds
The biopharma universe gathered in San Diego last week for the first face to face BIO International conference in three years. Turn-out was good but below the get-together in Philadelphia in 2019. That one topped out above 17,000 attendees according to the BIO website; whisper numbers this time around were in the region of 12,000. I […]
Biotech funding in a risk-off climate – does upstream trouble loom for pharma services providers?
Biotech funding is the key driver of innovation in the pharmaceutical industry and is essential in supporting the healthcare ecosystem. More than 80% of drugs marketed by large pharmaceutical companies were discovered and initially developed by biotechs1. Biotech companies also discovered more than 60% of FDA-approved “priority” drugs, which treat life-threatening conditions and offer significant […]
Crossrail opens – a big day for travellers to and workers in London
At Results Healthcare we execute transactions around the world, with active projects in North America, Europe and Asia Pacific, so we see ourselves as a global organisation with offices and employees in London and New York, so a blog on transport in London might seem oddly parochial, but the opening of Crossrail, or the Elizabeth […]
Partnering with Private Equity: Insights and perspectives from Tony Hill at Sideshow and Dominic Graham at Waterland Private Equity
In February of 2021, Sideshow, an independent digital group, partnered with Waterland Private Equity to support its ambitious growth plans to continue building a group of highly connected digital brands. One year on we caught up with Sideshow’s Tony Hill, Founder and CEO, and Dominic Graham, Investment Director at Waterland to discuss the journey to […]
DCAT’s Back / Back at DCAT
For the first time in forever it felt like the good old days were back in midtown Manhattan at everyone’s favourite pharma supply chain conference The hotels. The meetings. The dinners. Walking up and down Lexington Avenue and bumping into friends and colleagues. It was all happening again at DCAT last week in New York. […]
The growing impact of Environmental, Social, and Governance (“ESG”) on pharmaceutical supply chains.
The Russian invasion of Ukraine has been touted as the final nail in the coffin of globalisation, confirming the nationalisation of key industries and products. With respect to pharmaceutical manufacturing, this is accelerating a trend which has been ongoing for 10 years, the repatriation of drug manufacturing from Asia to the US and Europe has […]
Discovery CROs: what is the “balanced business model” and how is this valued?
Discovery Contract Research Organisations (“CROs”) essentially provide lab-based discovery services such as medicinal chemistry, biological screening etc to pharma companies and biotech, and this business segment has exploded in size, sophistication and value in recent years and is now a focus of both M&A and PE investment. This is covered in our forthcoming white paper […]
Predictions for Life Sciences Industries for 2022, and no ‘San Francisco’ This Year!
The Covid 19 pandemic continues to have a major impact on the healthcare industry, both positive if you are close to the discovery and provision of treatments for this infection and negative if you are selling certain other drugs, such as antibiotics or providing care services, which have been negatively impacted by this pandemic. However, […]
We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.